Enzyme	O
symbols	O
:	O
MvaE	O
acetyl-CoA	O
acetyltransferaseHMG-CoA	O
reductase	O
and	O
MvaS	O
HMG-CoA	O
synthase	O
from	O
Enterococcus	PROT
faecalis	O
;	O
ERG12	PROT
mevalonate	PROT
kinase	PROT
,	O
ERG8	PROT
phosphomevalonate	O
kinase	PROT
,	O
ERG19	O
mevalonate	PROT
pyrophosphate	O
decarboxylase	O
and	O
IDI1	PROT
IPP	O
isomerase	O
from	O
Saccharomyces	O
cerevisiae	O
;	O
IspS	O
isoprene	O
synthase	O
from	O
Populus	O
alba.Enzyme	O
symbols	O
:	O
MvaE	O
acetyl-CoA	O
acetyltransferaseHMG-CoA	O
reductase	O
and	O
MvaS	O
HMG-CoA	O
synthase	O
from	O
Enterococcus	PROT
faecalis	O
;	O
ERG12	PROT
mevalonate	PROT
kinase	PROT
,	O
ERG8	PROT
phosphomevalonate	O
kinase	PROT
,	O
ERG19	O
mevalonate	PROT
pyrophosphate	O
decarboxylase	O
and	O
IDI1	PROT
IPP	O
isomerase	O
from	O
Saccharomyces	O
cerevisiae	O
;	O
IspS	O
isoprene	O
synthase	O
from	O
Populus	O
alba	O
.	O

The	O
ability	O
of	O
the	O
R106W	PROT
and	O
Δ166	O
mutants	O
to	O
associate	O
with	O
chromosomes	O
implies	O
that	O
the	O
methyl-CpG-binding	O
domain	O
is	O
not	O
required	O
for	O
this	O
activity.To	O
date	O
eight	O
SVA	O
insertions	O
have	O
been	O
associated	O
with	O
disease	O
14	O
,15	O
,	O
these	O
include	O
for	O
example	O
a	O
SVA	O
in	O
the	O
3	O
’	O
UTR	O
of	O
the	O
fukutin	PROT
gene	O
which	O
causes	O
Fukyama-type	O
congenital	O
muscular	O
dystrophy	O
by	O
decreasing	O
mRNA	O
production	O
,	O
and	O
a	O
SVA	O
insertion	O
and	O
subsequent	O
14	O
kb	O
deletion	O
of	O
the	O
HLA-A	O
gene	O
locus	O
linked	O
with	O
leukaemia	O
16	O
,17	O
.	O

A	O
recent	O
study	O
to	O
determine	O
the	O
nature	O
of	O
SVA	O
retrotransposition	O
revealed	O
that	O
no	O
individual	O
domain	O
of	O
an	O
SVA	O
is	O
fundamental	O
for	O
this	O
to	O
occur	O
,	O
but	O
each	O
domain	O
differentially	O
affected	O
the	O
rate	O
at	O
which	O
retrotransposition	O
can	O
take	O
place	O
13.Thus	O
,	O
the	O
zebrafish	O
system	O
may	O
provide	O
a	O
genetically	O
and	O
embryologically	O
accessible	O
model	O
to	O
complement	O
investigations	O
in	O
mammalian	O
model	O
systems	O
.	O

It	O
has	O
been	O
suggested	O
that	O
suppression	O
of	O
MAZ	O
Myc-associated	O
zinc	O
finger	O
protein	O
may	O
be	O
associated	O
with	O
DNA	O
methyltransferase	O
I	O
,	O
the	O
key	O
factor	O
for	O
de	O
novo	O
DNA	O
methylation	O
73	O
,74.Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
mevalonate	O
blockade	O
suppresses	O
DKK-1	O
via	O
inhibited	O
geranylgeranylation	O
of	O
Cdc42	PROT
and	O
Rho	O
.	O

The	O
MeCP2	PROT
protein	O
contains	O
a	O
methyl-CpG-binding	O
domain	O
MBD	O
and	O
localizes	O
to	O
the	O
heterochromatin	O
where	O
it	O
is	O
believed	O
to	O
regulate	O
gene	O
expression	O
by	O
recruiting	O
histone	O
deacetylases	O
to	O
alter	O
chromatin	O
structure	O
11	O
,12.Previous	O
studies	O
demonstrated	O
a	O
critical	O
role	O
for	O
the	O
KRAB	O
zinc	O
finger	O
protein	O
ZFP57	O
in	O
the	O
maintenance	O
of	O
DNA	O
methylation	O
at	O
multiple	O
imprinted	O
germline	O
DMRs	O
in	O
mice	O
and	O
human	O
19	O
,	O
20	O
.	O

Gene	O
silencing	O
due	O
to	O
histone	O
modifications	O
appeared	O
to	O
reduce	O
the	O
benefits	O
of	O
using	O
CpGfree	PROT
to	O
improve	O
long-term	O
recombinant	O
protein	O
expression	O
stability	O
in	O
CHO	O
cells.On	O
the	O
right	O
,	O
MEP	O
pathway	O
steps	O
are	O
described	O
:	O
GAP	O
,	O
D-glyceraldehyde	O
3-phosphate	O
;	O
DXP	O
,	O
1-deoxy-D-xylulose	O
5-phosphate	O
;	O
MEP	O
,	O
2-C-methyl-D-erythritol	O
4-phosphate	O
;	O
CDP-ME	O
,4-diphosphocytidyl-2-C-methyl-D-erythritol	O
;	O
MEcPP	O
,	O
2-C-methyl-D-erythritol	O
2	O
,4-cyclodiphosphate	O
;	O
HMBPP	O
,	O
4-hydroxy-3-methylbut-2-enyl	O
diphosphate	O
;	O
IPP	O
,	O
isopentenyl	O
diphosphate	O
;	O
DMAPP	PROT
,	O
dimethylallyl	O
diphosphate	O
.	O

This	O
is	O
consistent	O
with	O
studies	O
demonstrating	O
that	O
methylation	O
of	O
a	O
CpG	O
within	O
the	O
binding	O
motif	O
is	O
necessary	O
for	O
ZFP57	O
binding	O
in	O
vitro	O
21.Apart	O
from	O
calponin	O
1	O
,	O
other	O
actin-binding	O
molecules	O
such	O
caldesmon	O
1	O
,	O
cortactin	O
and	O
palladin	PROT
were	O
also	O
identified	O
.	O

Also	O
,	O
some	O
miRNAs	PROT
appeared	O
to	O
be	O
methylated	O
in	O
their	O
promoter	O
region.This	O
process	O
requires	O
three	O
enzymes	O
,	O
including	O
mevalonate	PROT
kinase	PROT
,	O
phosphomevalonate	O
kinase	PROT
and	O
mevalonate	PROT
diphosphate	O
decarboxylase	O
18	O
.	O

Furthermore	O
we	O
observed	O
differential	O
methylation	O
of	O
one	O
CpG	O
in	O
MBD4	PROT
∆beta	O
0.08	O
,	O
a	O
methyl-CpG-binding	O
domain	O
protein	O
and	O
DNA	O
glycosylase	O
with	O
excision	O
activity	O
against	O
5-methyl	O
cytosine.Last	O
,	O
methyltransferase	O
enzymes	O
themselves	O
can	O
show	O
some	O
DNA-sequence	O
preferences	O
80	O
,	O
81	O
,	O
and	O
members	O
of	O
the	O
methyl-binding	O
proteins	O
family	O
e.g	O
.	O

Morpholinos	PROT
MOs	PROT
against	O
two	O
of	O
these	O
genes	O
have	O
been	O
characterized	O
,	O
and	O
both	O
lead	O
to	O
muscle	O
degeneration	O
Fukutin	PROT
related	O
protein	O
Q0PIP5_DANRE	O
,	O
LARGE	O
2	O
LARG2_DANRE	O
16	O
,17.The	O
extent	O
of	O
tissue-specific	O
DNA	O
methylation	O
differences	O
in	O
the	O
super-enhancer	O
regions	O
was	O
low	O
,	O
with	O
only	O
12.6	O
%	O
644	O
out	O
of	O
5111	O
of	O
them	O
showing	O
CpG	O
methylation	O
differences	O
from	O
different	O
normal	O
tissues	O
δ	O
hypomethylated	O
regions	O
HMRs	O
occupancy	O
>	O
10	O
%	O
;	O
Supplementary	O
methods	O
,	O
Figure	O
S4a	O
and	O
Table	PROT
S2	PROT
in	O
Additional	O
file	O
1	O
.	O

In	O
fact	O
,	O
there	O
is	O
growing	O
evidence	O
that	O
aberrant	O
expression	O
of	O
MBD	O
proteins	O
is	O
associated	O
with	O
human	O
cancers	O
8	O
,9.Additional	O
factors	O
,	O
possibly	O
functioning	O
in	O
various	O
protein	O
complexes	O
with	O
MeCP2	PROT
,	O
may	O
act	O
to	O
recruit	O
MeCP2	PROT
to	O
the	O
chromatin	O
.	O

In	O
the	O
native	O
MVA	O
pathway	O
,	O
MVA	O
is	O
phosphorylated	O
twice	O
and	O
decarboxylated	O
to	O
form	O
IPP.MXI1	O
and	O
MAX	O
Myc-associated	O
factor	O
X	O
both	O
interact	O
with	O
c-Myc	O
myelocytomatosis	O
oncogene	O
,	O
a	O
well-characterized	O
oncogene	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
methylation	O
sensitive	O
,	O
meaning	O
that	O
the	O
TF	O
motifs	O
contain	O
CpG	O
sites	O
and	O
,	O
thus	O
,	O
TF	O
binding	O
is	O
sensitive	O
to	O
methylation	O
status	O
at	O
those	O
sites	O
75	O
.	O

In	O
this	O
study	O
,	O
therefore	O
,	O
we	O
use	O
methyl-CpG	O
binding	O
domain	O
MBD	O
protein-based	O
enrichment	O
coupled	O
to	O
NGS	O
MBD-seq	O
to	O
assay	O
DNA	O
methylation	O
in	O
human	O
blood	O
21.This	O
process	O
typically	O
requires	O
five	O
reactions	O
,	O
including	O
a	O
two-step	O
phosphorylation	O
catalyzed	O
by	O
mevalonate	PROT
kinase	PROT
and	O
phosphomevalonate	O
kinase	PROT
,	O
a	O
one-step	O
decarboxylation	O
catalyzed	O
by	O
mevalonate	PROT
5-diphosphate	O
decarboxylase	O
,	O
a	O
one-step	O
isomerization	O
catalyzed	O
by	O
IPP	O
isomerase	O
and	O
a	O
one-step	O
dephosphorylation	O
catalyzed	O
by	O
isoprene	O
synthase	O
7	O
,	O
9	O
,	O
24	O
.	O

MBD9	O
is	O
a	O
protein	O
with	O
a	O
methyl	O
CpG	O
binding	O
domain	O
previously	O
identified	O
as	O
a	O
regulator	O
of	O
flowering	O
time	O
with	O
potential	O
roles	O
in	O
histone	O
H4	O
acetylation	O
23	O
,24.In	O
this	O
context	O
it	O
is	O
interesting	O
to	O
note	O
that	O
unlike	O
mammals	O
,	O
bacteria	O
,	O
plants	O
,	O
and	O
other	O
insects	O
,	O
the	O
levels	O
of	O
DNA	O
methylation	O
are	O
very	O
low	O
in	O
Drosophila	O
42	O
.	O

Accordingly	O
,	O
demethylation	O
of	O
the	O
5′ETS	O
rRNA	O
gene	O
sequences	O
and	O
activation	O
of	O
VAR1	O
suggest	O
that	O
AtNUC-L1	O
maintains	O
gene	O
methylation	O
required	O
for	O
accurate	O
nucleosome	O
position	O
for	O
transcription	O
Figure	O
8.While	O
an	O
ortholog	O
for	O
the	O
complete	O
MeCP2	PROT
protein	O
does	O
not	O
exist	O
in	O
Drosophila	O
,	O
methyl-CpG-binding	O
domains	O
are	O
conserved	O
from	O
flies	O
to	O
humans	O
13	O
.	O

3	O
,	O
Table	O
1.The	O
mevalonate	O
pathway	O
.	O

While	O
an	O
ortholog	O
for	O
the	O
complete	O
MeCP2	PROT
protein	O
does	O
not	O
exist	O
in	O
Drosophila	O
,	O
methyl-CpG-binding	O
domains	O
are	O
conserved	O
from	O
flies	O
to	O
humans	O
13.Other	O
notable	O
features	O
include	O
gene	O
clusters	O
for	O
a	O
mevalonate-independent	O
pathway	O
of	O
isoprenoid	O
production	O
and	O
a	O
type	O
VI	O
secretion	O
system	O
Island	O
3	O
of	O
strain	O
O6	O
,	O
a	O
chaperone-usher	O
fimbrial	O
biogenesis	O
pathway	O
Island	O
6	O
of	O
strain	O
SS101	PROT
,	O
and	O
an	O
indole-3-acetic	O
acid	O
uptake	O
and	O
catabolism	O
pathway	O
Island	O
3	O
of	O
BG33R	PROT
.	O

The	O
methyl-CpG-binding	O
domain	O
MBD	O
proteins	O
are	O
among	O
these	O
protein	O
families	O
that	O
bind	O
specifically	O
to	O
a	O
methylated	O
gene	O
and	O
mediate	O
transcriptional	O
repression	O
via	O
effects	O
on	O
chromatin	O
structure	O
.	O

Among	O
the	O
cargo	O
genes	O
of	O
these	O
islands	O
are	O
those	O
with	O
predicted	O
functions	O
as	O
components	O
of	O
restriction-modification	O
systems	O
Island	O
1	O
in	O
30-84	O
;	O
Island	O
1	O
in	O
Q8r1-96	O
,	O
assorted	O
transporters	O
Island	O
1	O
in	O
30-84	O
;	O
Islands	O
3	O
and	O
6	O
in	O
SS101	PROT
;	O
Islands	O
3	O
and	O
4	O
in	O
BG33R	PROT
,	O
transcriptional	O
regulators	O
Island	O
2	O
in	O
O6	O
;	O
Island	O
4	O
in	O
Q8r1-96	O
;	O
Island	O
2	O
and	O
4	O
in	O
Q2-87	O
;	O
Islands	O
2	O
,	O
4	O
,	O
and	O
6	O
in	O
SS101	PROT
;	O
Island	O
7	O
in	O
BG33R	PROT
,	O
two-component	O
signal	O
transduction	O
systems	O
Island	O
3	O
in	O
30-84	O
;	O
Islands	O
1	O
,	O
2	O
,	O
and	O
3	O
in	O
O6	O
;	O
Island	O
6	O
in	O
SS101	PROT
,	O
a	O
methyl-accepting	O
chemotaxis	O
protein	O
Island	O
4	O
in	O
SS101	PROT
,	O
a	O
polyphosphate	O
kinase	O
Island	O
3	O
in	O
30-84	O
;	O
Island	O
2	O
in	O
O6	O
,	O
a	O
TonB-dependent	O
outer-membrane	O
receptor	O
Island	O
1	O
in	O
O6	O
;	O
Island	O
3	O
in	O
BG33R	PROT
,	O
a	O
putative	O
β-lactamase	O
Island	O
4	O
in	O
SS101	PROT
,	O
a	O
UV	O
irradiation	O
resistance	O
protein	O
Island	O
4	O
in	O
SS101	PROT
,	O
and	O
a	O
diverse	O
array	O
of	O
conserved	O
hypothetical	O
proteins	O
all	O
strains.Top	O
proteins	O
enriched	O
in	O
the	O
old	O
TEC	O
included	O
cytoskeleton	O
organization	O
proteins	O
calponin	O
1	O
,	O
palladin	PROT
,	O
collagens	O
COL3A1	PROT
,	O
COL4A2	PROT
,	O
COL12A1	PROT
and	O
transforming	O
growth	O
factor	O
beta-induced	O
protein	O
TGFBI	O
Fig	O
.	O

To	O
date	O
eight	O
SVA	O
insertions	O
have	O
been	O
associated	O
with	O
disease	O
14	O
,15	O
,	O
these	O
include	O
for	O
example	O
a	O
SVA	O
in	O
the	O
3	O
’	O
UTR	O
of	O
the	O
fukutin	PROT
gene	O
which	O
causes	O
Fukyama-type	O
congenital	O
muscular	O
dystrophy	O
by	O
decreasing	O
mRNA	O
production	O
,	O
and	O
a	O
SVA	O
insertion	O
and	O
subsequent	O
14	O
kb	O
deletion	O
of	O
the	O
HLA-A	O
gene	O
locus	O
linked	O
with	O
leukaemia	O
16	O
,17.Moreover	O
,	O
loss	O
of	O
MeCP2	PROT
results	O
in	O
structural	O
alternation	O
of	O
the	O
nucleolus	O
in	O
cortical	O
neurons	O
45	O
,	O
raising	O
the	O
possibility	O
that	O
MeCP2	PROT
somehow	O
counteracts	O
condensin	O
II	O
in	O
neurons	O
.	O

Research	O
in	O
the	O
last	O
decade	O
has	O
linked	O
the	O
methyl-CpG-binding	O
protein	O
2	O
MeCP2	PROT
with	O
a	O
variety	O
of	O
related	O
neurological	O
disorders	O
1.Histone	O
modifications	O
were	O
also	O
identified	O
as	O
better	O
indicators	O
of	O
expression	O
stability	O
than	O
CpG	O
methylation	O
and	O
histone	O
binding	O
proteins	O
like	O
HP1	O
.	O

,	O
MeCP2	PROT
and	O
MBD2	PROT
,	O
while	O
lacking	O
sequence-specificity	O
,	O
participate	O
in	O
protein	O
complexes	O
that	O
bind	O
highly	O
methylated	O
CpG-rich	O
sequences	O
and	O
can	O
help	O
to	O
maintain	O
repressive	O
chromatin	O
82.The	O
second	O
genome-wide	O
DNA	O
methylation	O
screening	O
methodology	O
we	O
applied	O
,	O
to	O
the	O
same	O
eight	O
NB	O
cell	O
lines	O
,	O
was	O
MBD-seq	O
:	O
massively	O
parallel	O
sequencing	O
of	O
methylation-enriched	O
DNA	O
fragments	O
,	O
whereby	O
the	O
enrichment	O
is	O
based	O
on	O
the	O
capture	O
of	O
methylated	O
sheared	O
DNA	O
using	O
the	O
high	O
affinity	O
of	O
the	O
methyl-CpG-binding	O
domain	O
of	O
the	O
protein	O
MBD2	PROT
towards	O
methylated	O
cytosines	O
.	O

Another	O
quantification	O
measure	O
,	O
the	O
number	O
of	O
methylated	O
CpG	O
sites	O
per	O
unit	O
length	O
,	O
mCGlen	O
,	O
may	O
be	O
more	O
related	O
to	O
the	O
average	O
speed	O
reduction	O
of	O
the	O
elongating	O
polymerase.The	O
methyl	O
CpG	O
binding	O
protein	O
MeCP2	PROT
was	O
shown	O
to	O
interact	O
with	O
the	O
lamin	O
B	O
receptor	O
and	O
may	O
connect	O
DNA	O
methylation	O
with	O
nuclear	O
architecture	O
60	O
.	O

It	O
has	O
been	O
demonstrated	O
in	O
vitro	O
that	O
ZFP57	O
zinc	O
fingers	O
2–3	O
are	O
responsible	O
for	O
binding	O
motif	O
recognition	O
and	O
have	O
the	O
highest	O
affinity	O
when	O
a	O
central	O
CpG	O
dinucleotide	O
in	O
the	O
motif	O
is	O
fully	O
methylated	O
21	O
,	O
45.Enzymes	O
are	O
indicated	O
in	O
bold	O
:	O
AACT	O
,	O
acetoacetyl-CoA	O
thiolase	O
;	O
HMGS	PROT
,	O
HMG-CoA	O
synthase	O
;	O
HMGR	PROT
,	O
HMG-CoA	O
reductase	O
;	O
MVK	O
,	O
mevalonate	PROT
kinase	PROT
;	O
PMVK	O
,	O
5-phosphomevalonate	O
kinase	PROT
;	O
DPMD	O
,	O
5-diphosphomevalonate	O
decarboxylase	O
;	O
IDI	O
,	O
IPPDMAPP	PROT
isomerase	O
.	O

Here	O
we	O
show	O
that	O
the	O
methyl-CpG-binding	O
domain	O
is	O
not	O
necessary	O
for	O
association	O
of	O
the	O
MeCP2	PROT
protein	O
with	O
chromatin	O
in	O
polytene	O
chromosomes	O
Figures	O
1H-H	O
”	O
,	O
nor	O
is	O
it	O
required	O
to	O
produce	O
an	O
eye	O
phenotype	O
in	O
Drosophila	O
Figures	O
2D-D	O
”	O
.This	O
reversible	O
addition	O
of	O
methyl	O
groups	O
at	O
cytosines	O
within	O
CpG	O
dinucleotides	O
can	O
promote	O
the	O
recruitment	O
of	O
protein	O
complexes	O
that	O
repress	O
transcription	O
and	O
also	O
prevent	O
the	O
binding	O
of	O
transcription	O
factors	O
to	O
their	O
binding	O
motifs	O
15	O
,16	O
.	O

Indeed	O
,	O
several	O
studies	O
point	O
to	O
a	O
major	O
role	O
of	O
CpG	O
methylation	O
in	O
nucleosome	O
positioning	O
and	O
binding	O
of	O
multiples	O
protein	O
factors	O
could	O
be	O
involve	O
in	O
repositioning	O
of	O
nucleosome	O
57	O
,	O
58.It	O
has	O
been	O
reported	O
that	O
clusters	O
of	O
unmethylated	O
CpG	O
can	O
recruit	O
H3K4me3	O
,	O
a	O
modification	O
associated	O
with	O
sites	O
of	O
transcriptional	O
initiation	O
,	O
via	O
the	O
CpG	O
binding	O
protein	O
Cfp1	O
14	O
.	O

High	O
abundance	O
of	O
calponin	O
1	O
in	O
old	O
tenocyte	O
TEC	O
may	O
be	O
related	O
to	O
changes	O
in	O
ECM	O
content	O
that	O
affect	O
mechanical	O
properties	O
of	O
the	O
engineered	O
tissue	O
and	O
increase	O
mechanical	O
strain	O
detected	O
by	O
the	O
cells.The	O
MED-1	O
sequence	O
is	O
a	O
downstream	O
protein-binding	O
element	O
previously	O
linked	O
to	O
TATA-less	PROT
promoters	O
with	O
multiple	O
distinct	O
start	O
sites	O
Butler	O
and	O
Kadonaga	O
2002	O
.	O

Last	O
,	O
methyltransferase	O
enzymes	O
themselves	O
can	O
show	O
some	O
DNA-sequence	O
preferences	O
80	O
,	O
81	O
,	O
and	O
members	O
of	O
the	O
methyl-binding	O
proteins	O
family	O
e.g	O
.	O

In	O
the	O
previous	O
studies	O
,	O
several	O
research	O
groups	O
,	O
including	O
ours	O
,	O
established	O
pathways	O
for	O
the	O
conversion	O
of	O
MVA	O
to	O
isoprene.Similar	O
to	O
our	O
findings	O
,	O
whole-genome	O
bisulfite	O
sequencing	O
showed	O
that	O
approximately	O
36	O
%	O
of	O
identified	O
age-associated	O
,	O
differentially	O
methylated	O
regions	O
were	O
within	O
LADs	O
44	O
.	O

In	O
proliferating	O
cells	O
passive	O
loss	O
of	O
methylation	O
can	O
result	O
from	O
successive	O
rounds	O
of	O
replication	O
in	O
the	O
absence	O
of	O
restoration	O
of	O
CpG	O
methylation	O
by	O
DNMT1	O
UHFR1	O
,	O
or	O
an	O
initial	O
active	O
oxidation	O
of	O
methylated	O
cytosine	O
followed	O
by	O
replication-dependent	O
dilution	O
71.Then	O
,	O
using	O
the	O
enzyme	O
pyrophosphatase	O
or	O
phosphatase	O
,	O
IPP	O
can	O
be	O
converted	O
into	O
3-methyl-3-buten-1-ol	O
by	O
removing	O
the	O
pyrophosphates	O
19	O
.	O

In	O
this	O
sense	O
,	O
it	O
is	O
noteworthy	O
that	O
a	O
hypomorphic	O
mutation	O
of	O
Ncaph2	PROT
was	O
reported	O
to	O
specifically	O
affect	O
T-cell	O
differentiation	O
and	O
survival	O
in	O
mice	O
42	O
,	O
presumably	O
through	O
a	O
failure	O
in	O
condensin	O
II-dependent	O
structural	O
reorganization	O
of	O
interphase	O
chromatin	O
43.MBD-seq	O
has	O
been	O
demonstrated	O
to	O
be	O
sensitive	O
and	O
capable	O
of	O
identifying	O
differentially	O
methylated	O
regions	O
20–25	O
,	O
to	O
detect	O
previously	O
reported	O
robust	O
associations	O
26	O
,	O
and	O
to	O
produce	O
findings	O
that	O
replicate	O
using	O
more	O
sensitive	O
,	O
targeted	O
technologies	O
27	O
.	O

Such	O
epigenetic	O
alterations	O
primarily	O
involve	O
DNA	O
hypermethylation	O
events	O
within	O
the	O
promoter	O
regions	O
of	O
individual	O
candidate	O
genes.Consistent	O
with	O
these	O
findings	O
we	O
confirmed	O
that	O
the	O
majority	O
of	O
H3K4me3	O
enriched	O
loci	O
map	O
to	O
CGIs	O
in	O
human	O
and	O
mouse	O
ES	O
cells	O
74.6	O
and	O
84.1	O
%	O
respectively	O
.	O

Furthermore	O
,	O
a	O
recent	O
study	O
of	O
gene	O
expression	O
patterns	O
in	O
mice	O
that	O
either	O
lack	O
or	O
overexpress	O
MeCP2	PROT
suggests	O
that	O
many	O
genes	O
are	O
activated	O
by	O
MeCP2	PROT
41.Indeed	O
,	O
several	O
studies	O
point	O
to	O
a	O
major	O
role	O
of	O
CpG	O
methylation	O
in	O
nucleosome	O
positioning	O
and	O
binding	O
of	O
multiples	O
protein	O
factors	O
could	O
be	O
involve	O
in	O
repositioning	O
of	O
nucleosome	O
57	O
,	O
58	O
.	O

This	O
process	O
typically	O
requires	O
five	O
reactions	O
,	O
including	O
a	O
two-step	O
phosphorylation	O
catalyzed	O
by	O
mevalonate	PROT
kinase	PROT
and	O
phosphomevalonate	O
kinase	PROT
,	O
a	O
one-step	O
decarboxylation	O
catalyzed	O
by	O
mevalonate	PROT
5-diphosphate	O
decarboxylase	O
,	O
a	O
one-step	O
isomerization	O
catalyzed	O
by	O
IPP	O
isomerase	O
and	O
a	O
one-step	O
dephosphorylation	O
catalyzed	O
by	O
isoprene	O
synthase	O
7	O
,	O
9	O
,	O
24.While	O
these	O
techniques	O
are	O
less	O
biased	O
in	O
global	O
coverage	O
than	O
the	O
aforementioned	O
methods	O
,	O
they	O
are	O
most	O
effective	O
in	O
the	O
analysis	O
of	O
regions	O
,	O
rather	O
than	O
single	O
base	O
resolution	O
,	O
of	O
high	O
CpG	O
content	O
and	O
methylation	O
level	O
.	O

The	O
second	O
genome-wide	O
DNA	O
methylation	O
screening	O
methodology	O
we	O
applied	O
,	O
to	O
the	O
same	O
eight	O
NB	O
cell	O
lines	O
,	O
was	O
MBD-seq	O
:	O
massively	O
parallel	O
sequencing	O
of	O
methylation-enriched	O
DNA	O
fragments	O
,	O
whereby	O
the	O
enrichment	O
is	O
based	O
on	O
the	O
capture	O
of	O
methylated	O
sheared	O
DNA	O
using	O
the	O
high	O
affinity	O
of	O
the	O
methyl-CpG-binding	O
domain	O
of	O
the	O
protein	O
MBD2	PROT
towards	O
methylated	O
cytosines.Research	O
in	O
the	O
last	O
decade	O
has	O
linked	O
the	O
methyl-CpG-binding	O
protein	O
2	O
MeCP2	PROT
with	O
a	O
variety	O
of	O
related	O
neurological	O
disorders	O
1	O
.	O

In	O
subcutaneous	O
adipose	O
we	O
saw	O
differential	O
methylation	O
of	O
two	O
CpG	O
sites	O
within	O
DNA	O
methyl-transferase	O
DNMT3A	PROT
∆beta	O
0.11	O
,	O
0.08	O
and	O
DNMT3L	PROT
∆beta	O
0.09	O
which	O
can	O
act	O
with	O
DNMT3A	PROT
to	O
stimulate	O
de	O
novo	O
methylation	O
,	O
and	O
also	O
interacts	O
with	O
histone	O
deacetylase	O
1.Primary	O
antibodies	O
used	O
for	O
immunoblotting	O
are	O
as	O
follows	O
:	O
rabbit	O
anti-Perp	O
20	O
1:200	O
,	O
mouse	O
anti-desmoplakin	O
clone	O
115F	O
1:500	O
,	O
mouse	O
anti-desmoglein	O
12	O
clone	O
4B2	O
1:1	O
,000	O
,	O
chicken	O
anti-plakoglobin	O
1408	O
1:5	O
,000	O
,	O
mouse	O
anti-desmocollin	O
2	O
Abcam	O
,	O
Cambridge	O
,	O
MA	O
,	O
USA	O
;	O
1:5	O
,000	O
,	O
mouse	O
anti-β	O
actin	O
peroxidase	O
conjugate	O
Sigma	O
Chemical	O
Corp.	O
;	O
1:1	O
,000	O
,	O
mouse	O
anti-GAPDH	O
Fitzgerald	O
Laboratories	O
,	O
Acton	O
,	O
MA	O
,	O
USA	O
;	O
1:15	O
,000	O
.	O

Similar	O
phenotypes	O
are	O
recapitulated	O
in	O
mice	O
that	O
either	O
lack	O
or	O
overexpress	O
MECP2	PROT
,	O
thus	O
underscoring	O
the	O
importance	O
of	O
properly	O
regulating	O
MeCP2	PROT
levels	O
7–10.Here	O
we	O
show	O
that	O
the	O
methyl-CpG-binding	O
domain	O
is	O
not	O
necessary	O
for	O
association	O
of	O
the	O
MeCP2	PROT
protein	O
with	O
chromatin	O
in	O
polytene	O
chromosomes	O
Figures	O
1H-H	O
”	O
,	O
nor	O
is	O
it	O
required	O
to	O
produce	O
an	O
eye	O
phenotype	O
in	O
Drosophila	O
Figures	O
2D-D	O
”	O
.	O

87	O
compared	O
PolII	O
binding	O
in	O
human	O
LCLs	O
and	O
a	O
chimpanzee	O
blood	O
sample	O
using	O
ChIP-seq	O
and	O
found	O
divergence	O
at	O
a	O
substantial	O
subset	O
of	O
orthologous	O
genes	O
between	O
the	O
two	O
species.We	O
did	O
observe	O
decreased	O
methylation	O
after	O
gastric	O
bypass	O
and	O
weight	O
loss	O
within	O
one	O
DNA	O
methyl-transferase	O
DNMT3A	PROT
,	O
and	O
its	O
co-factor	O
DNMT3L	PROT
as	O
well	O
as	O
within	O
the	O
gene	O
for	O
MBD4	PROT
a	O
methyl-cytosine	O
binding	O
protein	O
and	O
DNA	O
glycosylase	O
.	O

The	O
divergent	O
promoters	O
drive	O
expression	O
of	O
ubiquitously	O
expressed	O
housekeeping	O
genes	O
,	O
encoding	O
the	O
TATA	PROT
binding	O
protein	O
and	O
proteasome	O
component-B1	O
in	O
the	O
case	O
of	O
the	O
TBP	O
locus	O
,	O
and	O
the	O
heterogeneous	O
ribonucleoprotein	O
A2B1	O
and	O
chromobox	O
homolog	O
3	O
in	O
the	O
case	O
of	O
the	O
RNP	O
locus.This	O
study	O
is	O
the	O
first	O
to	O
use	O
only	O
two-step	O
reactions	O
to	O
construct	O
a	O
new	O
pathway	O
for	O
the	O
conversion	O
of	O
MVA	O
to	O
isoprene	O
by	O
combining	O
the	O
oleT	PROT
gene	O
from	O
Jeotgalicoccus	O
species	O
and	O
ohyA	O
gene	O
from	O
Elizabethkingia	O
meningoseptica	O
.	O

,	O
MeCP2	PROT
and	O
MBD2	PROT
,	O
while	O
lacking	O
sequence-specificity	O
,	O
participate	O
in	O
protein	O
complexes	O
that	O
bind	O
highly	O
methylated	O
CpG-rich	O
sequences	O
and	O
can	O
help	O
to	O
maintain	O
repressive	O
chromatin	O
82	O
.	O

The	O
dashed	O
box	O
shows	O
the	O
traditional	O
pathway	O
for	O
MVA	O
conversion	O
to	O
isoprene	O
8	O
,	O
9	O
,	O
while	O
the	O
new	O
pathway	O
constructed	O
in	O
this	O
study	O
is	O
within	O
the	O
solid-lined	O
box.MeCP2	PROT
also	O
interacts	O
with	O
other	O
proteins	O
involved	O
in	O
transcriptional	O
repression	O
and	O
chromatin	O
remodeling	O
including	O
Sin3a	O
,	O
REST	O
and	O
Brahma	O
,	O
a	O
core	O
component	O
of	O
the	O
SWISNF	O
complex	O
14–16	O
.	O

Conversely	O
,	O
a	O
group	O
of	O
zinc-finger	O
TFs	O
,	O
including	O
the	O
BTBPOZ	O
family	O
proteins	O
KAISO	PROT
,	O
ZTB4	O
,	O
and	O
ZBTB38	O
,	O
as	O
well	O
as	O
the	O
Krüppel-associated	O
box	O
KRAB-domain	O
TF	O
family	O
member	O
ZFP57	O
,	O
all	O
recognize	O
methylated	O
CpGs	PROT
within	O
DNA	O
sequence	O
motifs	O
and	O
can	O
act	O
as	O
repressors	O
by	O
perpetuating	O
local	O
CpG	O
hypermethylation	O
77.By	O
contrast	O
,	O
unmodified	O
CpG	O
is	O
recognized	O
by	O
proteins	O
such	O
as	O
the	O
histone	O
lysine	O
demethylase	O
Kdm2a	O
,	O
and	O
Cfp1	O
,	O
a	O
protein	O
that	O
recruits	O
a	O
Setd1	O
H3K4	O
methyltransferase	O
complex	O
19	O
,20	O
.	O

Some	O
studies	O
have	O
shown	O
that	O
nuclear	O
architecture	O
could	O
be	O
altered	O
during	O
normal	O
aging	O
beyond	O
just	O
modifications	O
connected	O
with	O
premature	O
aging	O
syndromes	O
59.The	O
divergent	O
promoters	O
drive	O
expression	O
of	O
ubiquitously	O
expressed	O
housekeeping	O
genes	O
,	O
encoding	O
the	O
TATA	PROT
binding	O
protein	O
and	O
proteasome	O
component-B1	O
in	O
the	O
case	O
of	O
the	O
TBP	O
locus	O
,	O
and	O
the	O
heterogeneous	O
ribonucleoprotein	O
A2B1	O
and	O
chromobox	O
homolog	O
3	O
in	O
the	O
case	O
of	O
the	O
RNP	O
locus	O
.	O

Finally	O
,	O
the	O
commonly-used	O
density	O
measure	O
mCGCG	O
represents	O
a	O
comparison	O
between	O
methylated	O
and	O
unmethylated	O
CpG	O
sites	O
in	O
a	O
given	O
genomic	O
region	O
,	O
which	O
may	O
reflect	O
the	O
“	O
competitiveness	O
”	O
of	O
the	O
region	O
for	O
events	O
such	O
as	O
protein	O
binding.Our	O
previous	O
studies	O
showed	O
that	O
with	O
these	O
large	O
CpG	O
island-containing	O
fragments	O
,	O
active	O
transcription	O
from	O
the	O
endogenous	O
promoters	O
was	O
maintained	O
even	O
upon	O
integration	O
into	O
centromeric	O
heterochromatin	O
,	O
that	O
single	O
copy	O
integration	O
at	O
different	O
sites	O
gave	O
very	O
similar	O
levels	O
of	O
gene	O
expression	O
,	O
and	O
that	O
position	O
effect	O
variegation	O
was	O
greatly	O
reduced	O
9	O
.	O

Methylated	O
DNA	O
immunoprecipitation	O
sequencing	O
MeDIP-seq	O
and	O
Methyl-Binding	O
Domain	O
sequencing	O
MBD-seq	O
capture	O
the	O
methylated	O
fraction	O
of	O
genomic	O
DNA	O
with	O
5-methylcytosine-specific	O
antibodies	O
and	O
MBD2	PROT
protein	O
17–19	O
,	O
respectively	O
,	O
and	O
are	O
followed	O
by	O
next-generation	O
sequencing.We	O
also	O
analyzed	O
expression	O
of	O
an	O
interesting	O
DS-DM	O
gene	O
from	O
the	O
fetal	O
brain	O
data	O
,	O
GLI4	O
.	O

Similarly	O
,	O
methylome	O
mapping	O
studies	O
have	O
highlighted	O
genes	O
that	O
are	O
perfectly	O
conserved	O
in	O
their	O
protein-coding	O
sequences	O
,	O
yet	O
show	O
significant	O
differences	O
in	O
CpG	O
methylation	O
levels	O
in	O
their	O
regulatory	O
sequences	O
between	O
humans	O
and	O
chimpanzees	O
100	O
,	O
101	O
.	O

As	O
examples	O
of	O
super-enhancer	O
tissue-specific	O
DNA	O
methylation	O
we	O
can	O
cite	O
the	O
genes	O
encoding	O
the	O
RNA-binding	O
protein	O
QKI	O
involved	O
in	O
myelinization	O
and	O
oligodendrocyte	O
differentiation	O
,	O
which	O
is	O
unmethylated	O
in	O
white	O
brain	O
matter	O
but	O
heavily	O
methylated	O
in	O
all	O
other	O
normal	O
tissues	O
Figure	O
S5a	O
in	O
Additional	O
file	O
1	O
,	O
and	O
lymphoblastic	O
leukemia-associated	O
hematopoiesis	O
regulator	O
1	O
LYL1	PROT
;	O
plays	O
a	O
role	O
in	O
blood	O
vessel	O
maturation	O
and	O
hematopoiesis	O
,	O
which	O
is	O
unmethylated	O
in	O
CD19+	O
cells	O
but	O
hypermethylated	O
in	O
all	O
other	O
normal	O
tissues	O
Figure	O
S5b	O
in	O
Additional	O
file	O
1.The	O
MeCP2	PROT
protein	O
contains	O
a	O
methyl-CpG-binding	O
domain	O
MBD	O
and	O
localizes	O
to	O
the	O
heterochromatin	O
where	O
it	O
is	O
believed	O
to	O
regulate	O
gene	O
expression	O
by	O
recruiting	O
histone	O
deacetylases	O
to	O
alter	O
chromatin	O
structure	O
11	O
,12	O
.	O

The	O
DS-DM	O
in	O
this	O
gene	O
is	O
also	O
localized	O
to	O
the	O
promoter	O
,	O
but	O
there	O
is	O
some	O
prior	O
evidence	O
that	O
promoter	O
methylation	O
may	O
normally	O
activate	O
transcription	O
of	O
NLGN2	O
:	O
MeCP2	PROT
,	O
a	O
methylated	O
CpG-binding	PROT
protein	PROT
that	O
can	O
either	O
activate	O
or	O
repress	O
genes	O
and	O
associates	O
with	O
the	O
transcriptional	O
activator	O
CREB1	O
27	O
,	O
can	O
bind	O
one	O
of	O
the	O
Nlgn2	O
promoters	O
in	O
mice	O
,	O
and	O
activate	O
transcription	O
in	O
reporter	O
assays	O
28.Sequencing	O
yielded	O
4.4	O
to	O
8.6	O
million	O
paired-end	O
reads	O
,	O
depending	O
on	O
the	O
cell	O
line	O
,	O
and	O
after	O
peak	O
calling	O
70	O
,816	O
to	O
112	O
,412	O
peaks	O
were	O
detected	O
,	O
representing	O
genomic	O
regions	O
methylated	O
in	O
the	O
corresponding	O
cell	O
line	O
.	O

Enzymes	O
are	O
indicated	O
in	O
bold	O
:	O
AACT	O
,	O
acetoacetyl-CoA	O
thiolase	O
;	O
HMGS	PROT
,	O
HMG-CoA	O
synthase	O
;	O
HMGR	PROT
,	O
HMG-CoA	O
reductase	O
;	O
MVK	O
,	O
mevalonate	PROT
kinase	PROT
;	O
PMVK	O
,	O
5-phosphomevalonate	O
kinase	PROT
;	O
DPMD	O
,	O
5-diphosphomevalonate	O
decarboxylase	O
;	O
IDI	O
,	O
IPPDMAPP	PROT
isomerase.Here	O
we	O
demonstrate	O
this	O
in	O
vivo	O
for	O
the	O
endogenous	O
full-length	O
protein	O
,	O
showing	O
that	O
ZFP57	O
always	O
follows	O
the	O
methylated	O
allele	O
in	O
cases	O
of	O
both	O
imprinted	O
Fig	O
.	O

This	O
reversible	O
addition	O
of	O
methyl	O
groups	O
at	O
cytosines	O
within	O
CpG	O
dinucleotides	O
can	O
promote	O
the	O
recruitment	O
of	O
protein	O
complexes	O
that	O
repress	O
transcription	O
and	O
also	O
prevent	O
the	O
binding	O
of	O
transcription	O
factors	O
to	O
their	O
binding	O
motifs	O
15	O
,16.In	O
addition	O
,	O
single	O
CpG	O
loci	O
within	O
HDAC7	O
∆beta	O
0.08	O
and	O
HDAC10	PROT
∆beta	O
0.06	O
were	O
more	O
methylated	O
before	O
weight	O
loss	O
,	O
with	O
HDAC4	PROT
showing	O
a	O
mixed	O
differential	O
methylation	O
signature	O
,	O
two	O
CpG	O
sites	O
hypermethylated	O
∆beta	O
0.09	O
,	O
0.10	O
and	O
one	O
hypomethylated	O
∆beta	O
−0.11	O
before	O
weight	O
loss	O
.	O

On	O
the	O
left	O
,	O
MVA	O
pathway	O
is	O
represented.On	O
the	O
other	O
hand	O
,	O
it	O
has	O
been	O
shown	O
that	O
overexpression	O
of	O
methyl-CpG-binding	O
protein	O
2	O
MeCP2	PROT
,	O
whose	O
mutations	O
cause	O
the	O
neurodevelopmental	O
disorder	O
Rett	PROT
syndrome	O
44	O
,	O
induce	O
hyperclustering	O
of	O
chromocenters	O
in	O
mouse	O
cells	O
30	O
,	O
31	O
.	O

The	O
methyl	O
CpG	O
binding	O
protein	O
MeCP2	PROT
was	O
shown	O
to	O
interact	O
with	O
the	O
lamin	O
B	O
receptor	O
and	O
may	O
connect	O
DNA	O
methylation	O
with	O
nuclear	O
architecture	O
60.Finally	O
,	O
the	O
commonly-used	O
density	O
measure	O
mCGCG	O
represents	O
a	O
comparison	O
between	O
methylated	O
and	O
unmethylated	O
CpG	O
sites	O
in	O
a	O
given	O
genomic	O
region	O
,	O
which	O
may	O
reflect	O
the	O
“	O
competitiveness	O
”	O
of	O
the	O
region	O
for	O
events	O
such	O
as	O
protein	O
binding	O
.	O

ERG10	O
–	O
acetyl-CoA	O
acetyltransferase	O
,	O
ERG13	O
–	O
3-hydroxy-3-methylglutaryl-CoA	O
synthase	O
,	O
human	O
HMGR	PROT
and	O
yeast	O
HMG1	O
,	O
HMG2	O
3-hydroxy-3-methylglutaryl-Co	O
A	O
reductase	O
1	O
and	O
2	O
,	O
FPP1	O
–	O
farnesyl	O
pyrophosphate	O
synthase	O
,	O
ERG1	O
–	O
squalene	O
monooxygenase	O
,	O
ERG6	PROT
–	O
delta24-sterol	O
C-methyltransferase	O
,	O
ERG3	O
–	O
C-5	O
sterol	O
desaturase	O
,	O
COQ3	O
–	O
3	O
,4-dihydroxy-5-hexaprenylbenzoatemethyltransferase	O
,	O
COQ2	PROT
–	O
para-hydroxybenzoate-polyprenyl	O
transferase	O
,	O
CAT5	PROT
–	O
ubiquinone	O
biosynthesis	O
monooxygenase	O
,	O
BTS1	PROT
–	O
geranylgeranyl	O
diphosphate	O
synthase	O
,	O
RER2	O
–	O
cis-prenyltransferase	O
,	O
SEC59	O
–	O
dolichol	O
kinase.Similarly	O
,	O
methylome	O
mapping	O
studies	O
have	O
highlighted	O
genes	O
that	O
are	O
perfectly	O
conserved	O
in	O
their	O
protein-coding	O
sequences	O
,	O
yet	O
show	O
significant	O
differences	O
in	O
CpG	O
methylation	O
levels	O
in	O
their	O
regulatory	O
sequences	O
between	O
humans	O
and	O
chimpanzees	O
100	O
,	O
101	O
.	O

For	O
example	O
,	O
5mCpG	O
is	O
specifically	O
recognized	O
by	O
methyl-CpG-binding	O
proteins	O
,	O
a	O
number	O
of	O
which	O
are	O
associated	O
with	O
histone	O
deacetylases	O
and	O
other	O
histone-modifying	O
enzymes	O
1	O
,17	O
,18.Relevant	O
to	O
hap-ASM	O
,	O
in	O
our	O
recent	O
work	O
,	O
we	O
used	O
cross-species	O
comparisons	O
of	O
DNA	O
sequences	O
and	O
methylation	O
patterns	O
to	O
test	O
variation	O
in	O
CTCF-binding	O
sites	O
as	O
an	O
underlying	O
mechanism	O
.	O

Primary	O
antibodies	O
used	O
for	O
immunoblotting	O
are	O
as	O
follows	O
:	O
rabbit	O
anti-Perp	O
20	O
1:200	O
,	O
mouse	O
anti-desmoplakin	O
clone	O
115F	O
1:500	O
,	O
mouse	O
anti-desmoglein	O
12	O
clone	O
4B2	O
1:1	O
,000	O
,	O
chicken	O
anti-plakoglobin	O
1408	O
1:5	O
,000	O
,	O
mouse	O
anti-desmocollin	O
2	O
Abcam	O
,	O
Cambridge	O
,	O
MA	O
,	O
USA	O
;	O
1:5	O
,000	O
,	O
mouse	O
anti-β	O
actin	O
peroxidase	O
conjugate	O
Sigma	O
Chemical	O
Corp.	O
;	O
1:1	O
,000	O
,	O
mouse	O
anti-GAPDH	O
Fitzgerald	O
Laboratories	O
,	O
Acton	O
,	O
MA	O
,	O
USA	O
;	O
1:15	O
,000.We	O
confirmed	O
the	O
identity	O
of	O
ems_2_129	O
via	O
introgression	O
of	O
the	O
mbd9-3	O
insertional	O
allele	O
into	O
an	O
atxr56	O
background	O
,	O
and	O
by	O
performing	O
complementation	O
analysis	O
Fig	O
4E	O
.	O

This	O
motif	O
was	O
found	O
around	O
35.9	O
%	O
of	O
the	O
hypomethylated	O
copies	O
of	O
these	O
discordant	O
CpG	O
sites	O
but	O
at	O
only	O
5.04	O
%	O
of	O
the	O
matching	O
hypermethylated	O
copies	O
P	O
=	O
1	O
×	O
10−12.In	O
this	O
study	O
,	O
therefore	O
,	O
we	O
use	O
methyl-CpG	O
binding	O
domain	O
MBD	O
protein-based	O
enrichment	O
coupled	O
to	O
NGS	O
MBD-seq	O
to	O
assay	O
DNA	O
methylation	O
in	O
human	O
blood	O
21	O
.	O

On	O
the	O
other	O
hand	O
,	O
it	O
has	O
been	O
shown	O
that	O
overexpression	O
of	O
methyl-CpG-binding	O
protein	O
2	O
MeCP2	PROT
,	O
whose	O
mutations	O
cause	O
the	O
neurodevelopmental	O
disorder	O
Rett	PROT
syndrome	O
44	O
,	O
induce	O
hyperclustering	O
of	O
chromocenters	O
in	O
mouse	O
cells	O
30	O
,	O
31.Loss	O
of	O
MeCP2	PROT
function	O
causes	O
classic	O
Rett	PROT
syndrome	O
RTT	O
,	O
but	O
can	O
also	O
lead	O
to	O
related	O
neurological	O
conditions	O
with	O
symptoms	O
that	O
include	O
autism	O
,	O
mild	O
or	O
severe	O
mental	O
retardation	O
with	O
seizures	O
,	O
or	O
learning	O
disabilities	O
2	O
,3	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
such	O
genes.Additionally	O
,	O
the	O
hypomethylation	O
of	O
repetitive	O
elements	O
can	O
occur	O
and	O
leads	O
to	O
genomic	O
instability	O
17	O
,18	O
,	O
and	O
alterations	O
in	O
histone	O
protein	O
modifications	O
can	O
have	O
profound	O
consequences	O
that	O
contribute	O
to	O
cancer	O
and	O
define	O
an	O
epigenetic	O
signature	O
of	O
tumorigenesis	O
16	O
,19	O
,20	O
.	O

As	O
an	O
alternative	O
to	O
WGBS	PROT
,	O
enrichment	O
for	O
the	O
methylated	O
genomic	O
fraction	O
followed	O
by	O
NGS	O
can	O
yield	O
information	O
on	O
many	O
millions	O
of	O
methylation	O
sites	O
20.Furthermore	O
we	O
observed	O
differential	O
methylation	O
of	O
one	O
CpG	O
in	O
MBD4	PROT
∆beta	O
0.08	O
,	O
a	O
methyl-CpG-binding	O
domain	O
protein	O
and	O
DNA	O
glycosylase	O
with	O
excision	O
activity	O
against	O
5-methyl	O
cytosine	O
.	O

Equal	O
amounts	O
of	O
total	O
protein	O
for	O
each	O
sample	O
were	O
subjected	O
to	O
Western	O
blot	O
analysis	O
using	O
standard	O
protocols.Conversely	O
,	O
a	O
group	O
of	O
zinc-finger	O
TFs	O
,	O
including	O
the	O
BTBPOZ	O
family	O
proteins	O
KAISO	PROT
,	O
ZTB4	O
,	O
and	O
ZBTB38	O
,	O
as	O
well	O
as	O
the	O
Krüppel-associated	O
box	O
KRAB-domain	O
TF	O
family	O
member	O
ZFP57	O
,	O
all	O
recognize	O
methylated	O
CpGs	PROT
within	O
DNA	O
sequence	O
motifs	O
and	O
can	O
act	O
as	O
repressors	O
by	O
perpetuating	O
local	O
CpG	O
hypermethylation	O
77	O
.	O

In	O
contrast	O
to	O
STK19	PROT
,	O
Q-PCR	O
for	O
NLGN2	O
mRNA	O
revealed	O
increased	O
mRNA	O
expression	O
in	O
the	O
DS	O
brains	O
Figure	PROT
S18	PROT
in	O
Additional	O
file	O
1.Secondary	O
antibodies	O
included	O
HRP	O
goat	O
anti-mouse	O
1:5	O
,000	O
,	O
HRP	O
goat	O
anti-chicken	O
1:5	O
,000	O
,	O
HRP	O
goat	O
anti-rabbit	O
1:5	O
,000	O
;	O
Jackson	O
Immunoresearch	O
,	O
West	O
Grove	O
,	O
PA	O
,	O
USA	O
.	O

Apart	O
from	O
calponin	O
1	O
,	O
other	O
actin-binding	O
molecules	O
such	O
caldesmon	O
1	O
,	O
cortactin	O
and	O
palladin	PROT
were	O
also	O
identified.A	O
protein	O
microarray-based	O
approach	O
for	O
surveying	O
purified	O
human	O
TFs	O
revealed	O
numerous	O
examples	O
,	O
typified	O
by	O
the	O
Krüppel-like	O
zinc-finger	O
domain	O
protein	O
KLF4	PROT
,	O
which	O
showed	O
methylated	O
CpG-dependent	O
DNA-binding	O
activities	O
78	O
.	O

This	O
process	O
requires	O
three	O
enzymes	O
,	O
including	O
mevalonate	PROT
kinase	PROT
,	O
phosphomevalonate	O
kinase	PROT
and	O
mevalonate	PROT
diphosphate	O
decarboxylase	O
18.MBD9	O
is	O
a	O
protein	O
with	O
a	O
methyl	O
CpG	O
binding	O
domain	O
previously	O
identified	O
as	O
a	O
regulator	O
of	O
flowering	O
time	O
with	O
potential	O
roles	O
in	O
histone	O
H4	O
acetylation	O
23	O
,24	O
.	O

These	O
regions	O
are	O
structurally	O
similar	O
,	O
containing	O
dual	O
divergently	O
transcribed	O
promoters	O
embedded	O
within	O
an	O
extended	O
methylation-free	O
CpG	O
island.The	O
DS-DM	O
in	O
this	O
gene	O
is	O
also	O
localized	O
to	O
the	O
promoter	O
,	O
but	O
there	O
is	O
some	O
prior	O
evidence	O
that	O
promoter	O
methylation	O
may	O
normally	O
activate	O
transcription	O
of	O
NLGN2	O
:	O
MeCP2	PROT
,	O
a	O
methylated	O
CpG-binding	PROT
protein	PROT
that	O
can	O
either	O
activate	O
or	O
repress	O
genes	O
and	O
associates	O
with	O
the	O
transcriptional	O
activator	O
CREB1	O
27	O
,	O
can	O
bind	O
one	O
of	O
the	O
Nlgn2	O
promoters	O
in	O
mice	O
,	O
and	O
activate	O
transcription	O
in	O
reporter	O
assays	O
28	O
.	O

We	O
isolated	O
another	O
suppressor	O
of	O
the	O
extra	O
DNA	O
in	O
atxr56	O
mutants	O
,	O
ems_2_129	O
,	O
which	O
we	O
mapped	O
via	O
whole-genome	O
re-sequencing	O
to	O
a	O
nonsense	O
mutation	O
at	O
mbd9	O
At3g01460	O
;	O
Fig	O
4A–4D.In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
these	O
quantification	O
measures	O
used	O
to	O
represent	O
methylation	O
levels	O
at	O
a	O
given	O
genomic	O
region	O
could	O
exhibit	O
drastically	O
different	O
patterns	O
when	O
analyzed	O
together	O
with	O
gene	O
expression	O
and	O
histone	O
modification	O
signals	O
.	O

In	O
addition	O
,	O
treatment	O
of	O
cells	O
with	O
Rho-associated	O
protein	O
kinase	O
inhibitors	O
Y-27632	O
and	O
H-1152P	O
significantly	O
decreased	O
DKK-1	O
Figure	O
4F.In	O
this	O
context	O
,	O
AtNUC-L1	O
activity	O
might	O
be	O
required	O
for	O
rRNA	O
gene	O
methylation	O
or	O
demethylation	O
to	O
repress	O
or	O
activates	O
RNA	O
Pol	O
I	O
transcription	O
.	O

Visual	O
inspection	O
suggests	O
that	O
many	O
CpG-deficient	O
orphans	O
which	O
score	O
as	O
H3K4me3-negative	O
possess	O
this	O
modification	O
at	O
levels	O
below	O
the	O
detection	O
limit	O
of	O
ChIP-seq.Retrotransposition	O
events	O
are	O
repressed	O
in	O
somatic	O
cells	O
via	O
epigenetic	O
modifications	O
and	O
post	O
transcriptional	O
suppression	O
but	O
there	O
is	O
recent	O
evidence	O
for	O
these	O
events	O
occurring	O
in	O
the	O
adult	O
brain	O
and	O
their	O
insertions	O
are	O
associated	O
with	O
protein	O
coding	O
genes	O
active	O
in	O
the	O
brain	O
18	O
.	O

79	O
showed	O
that	O
most	O
major	O
classes	O
of	O
TFs	O
,	O
including	O
bHLH	PROT
,	O
bZIP	PROT
,	O
and	O
ETS	O
,	O
bind	O
preferentially	O
to	O
unmethylated	O
DNA	O
,	O
whereas	O
other	O
TFs	O
,	O
such	O
as	O
homeodomain	O
,	O
POU	O
,	O
and	O
NFAT	O
,	O
bind	O
preferentially	O
to	O
methylated	O
DNA.Transgelin	O
,	O
cytoskeletal	O
protein	O
previously	O
referred	O
to	O
as	O
cellular	O
biomarker	O
of	O
ageing	O
55	O
,	O
demonstrated	O
less	O
than	O
two-fold	O
difference	O
in	O
abundance	O
between	O
young	O
and	O
old	O
TEC	O
.	O

It	O
has	O
been	O
reported	O
that	O
clusters	O
of	O
unmethylated	O
CpG	O
can	O
recruit	O
H3K4me3	O
,	O
a	O
modification	O
associated	O
with	O
sites	O
of	O
transcriptional	O
initiation	O
,	O
via	O
the	O
CpG	O
binding	O
protein	O
Cfp1	O
14.OleTJE	O
from	O
Jeotgalicoccus	O
species	O
;	O
OhyAEM	PROT
from	O
Elizabethkingia	O
meningoseptica	O
.	O

